Trial intelligence / Profile preview

Silver diamine fluoride for initial proximal enamel caries in posterior teeth

TCTR20190727002Phase 0Recruiting

Sponsor
Chulalongkorn University
Start
Jul 2019
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 0, randomised, open-label trial of silver diamine fluoride in carious lesion (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Remineralization of enamel caries. Started Jul 2019; status: recruiting.

02

Drugs

silver diamine fluoride
03

Conditions

carious lesion

Beyond the preview

Go deeper on TCTR20190727002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190727002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call